Boothbay Fund Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Sell |
56,464
-70,366
| -55% | -$262K | ﹤0.01% | 1039 |
|
|
2025
Q1 | $350K | Hold |
126,830
| – | – | 0.01% | 840 |
|
|
2024
Q4 | $703K | Sell |
126,830
-6
| -0% | -$33 | 0.02% | 629 |
|
|
2024
Q3 | $1.06M | Sell |
126,836
-39,804
| -24% | -$332K | 0.02% | 601 |
|
|
2024
Q2 | $1.13M | Buy |
166,640
+151,208
| +980% | +$1.03M | 0.03% | 572 |
|
|
2024
Q1 | $101K | Sell |
15,432
-10,934
| -41% | -$71.7K | ﹤0.01% | 1241 |
|
|
2023
Q4 | $171K | Hold |
26,366
| – | – | ﹤0.01% | 1198 |
|
|
2023
Q3 | $133K | Sell |
26,366
-24,374
| -48% | -$123K | ﹤0.01% | 1310 |
|
|
2023
Q2 | $444K | Sell |
50,740
-76,812
| -60% | -$672K | 0.01% | 974 |
|
|
2023
Q1 | $1.51M | Buy |
127,552
+1,670
| +1% | +$19.8K | 0.03% | 669 |
|
|
2022
Q4 | $1.28M | Sell |
125,882
-9,837
| -7% | -$100K | 0.03% | 653 |
|
|
2022
Q3 | $799K | Buy |
135,719
+29,007
| +27% | +$171K | 0.02% | 871 |
|
|
2022
Q2 | $265K | Buy |
+106,712
| New | +$265K | 0.01% | 1331 |
|